台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    195.0
  • 漲跌
    ▼11.0
  • 漲幅
    -5.34%
  • 成交量
    563
  • 產業
    上櫃 生技醫療類股▼0.02%
  • 66人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
易威 (1799)籌碼相關-群益金鼎 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/09/0420214.8300.00207.00208022.49%
2024/09/0200.000213.00222.5007980.00%
2024/08/3000.000.2219.00216.00-0.2792-0.02%
2024/08/2935.2214.6600.00221.0035.27954.42%
2024/08/270221.008.1223.65220.00-8.1785-1.03%
2024/08/220227.5000.00221.5007980.00%
2024/08/210222.7500.00225.0008020.00%
2024/08/2021.1212.7400.00216.0021.18062.61%
2024/08/1942196.6820200.40201.50228202.68%
2024/08/1200.000.2200.00198.00-0.2835-0.02%
2024/08/0920202.6800.00203.50208242.43%
2024/08/08131186.5800.00187.0013179416.48% 大買/鉅額交易
2024/08/0600.000.2172.17171.00-0.2777-0.02%
2024/08/050.1186.000.1174.05180.0007680.00%
2024/08/0255180.422.1181.28177.5052.97497.06%
2024/08/010.1171.080.1170.27175.50-0.1732-0.01%
2024/07/310.1153.480.1158.93161.0007270.00%
2024/07/3025.1147.3800.00148.0025.17163.50%
2024/07/2900.000.1140.00141.50-0.1708-0.01%
2024/07/2600.001155.00148.00-1700-0.14%
2024/07/2300.006159.50160.00-6685-0.88%
2024/07/221164.001.1164.98164.00-0.1667-0.01%
2024/07/1921.1185.15150187.50182.00-128.9650-19.81% 大賣/鉅額交易
2024/07/186.3188.4000.00196.506.36111.03%
2024/07/1720180.430191.50191.00205893.39%
2024/07/16100170.384167.00174.509656616.93%
2024/07/1535163.7400.00164.50355546.32%
2024/07/1220161.101.5154.79162.0018.55443.41%
2024/07/1120.1149.1000.00149.0020.15313.78%
2024/07/0900.000.4138.75139.00-0.4499-0.08%
2024/07/0800.001137.50138.50-1493-0.20%
2024/07/0400.002126.00126.00-2477-0.42%
2024/07/0375.1127.7300.00124.5075.147415.83%
2024/07/020.3137.501135.00138.00-0.7446-0.16%
2024/07/0125137.5000.00137.50254355.74%
2024/06/2850122.781129.00130.004941311.85%
2024/06/240.1104.0000.00103.000.13680.01%
2024/06/19199.5000.00101.5013740.27%
2024/06/0500.00199.0098.60-1315-0.32%
2024/06/0400.00196.8096.00-1316-0.32%
2024/06/03193.2000.0093.0013150.32%
2024/05/29197.501100.0094.5003190.00%
2024/05/24199.001299.53105.00-11298-3.68%
2024/05/20285.0000.0086.3022380.84%
2024/04/0800.000.268.5068.90-0.2251-0.09%
2024/03/251168.0500.0069.80112374.63%
2024/03/1800.001059.5259.60-10226-4.42%
2024/03/1200.001060.1059.90-10222-4.50%
2024/02/16153.4000.0052.0011830.55%
2023/12/2700.000.740.9041.50-0.7237-0.29%
2023/11/0800.00433.6033.60-4147-2.72%
2023/11/0700.00232.1032.90-2144-1.38%
2023/11/0300.00529.9530.00-5140-3.56%
2023/11/0100.00628.4628.80-6136-4.40%
2023/10/3100.00229.6530.10-2132-1.51%
2023/10/27432.2500.0032.4041223.27%
2023/10/24329.8300.0029.503883.39%
2023/10/23129.1000.0029.001851.17%
2023/10/18527.651227.6728.05-771-9.79%
2023/10/17225.0000.0025.502385.22%
2023/10/16124.3000.0024.551333.02%
2023/10/13424.2000.0024.1043013.19%
2023/09/1500.00221.2321.10-235-5.58%
2023/09/1300.00321.0021.20-337-8.08%
2023/09/0600.00521.0521.05-542-11.70%
2023/08/1700.00621.9621.65-677-7.77%
2023/08/0800.00522.4122.65-578-6.40%
2023/07/3100.00122.9022.90-182-1.21%
2023/07/2500.00322.5722.60-381-3.69%
2023/07/13323.0500.0022.903803.73%
2023/06/12222.5500.0022.8021201.66%
2023/06/06423.63523.7124.10-1139-0.72%
2023/06/05124.6000.0024.8011370.73%
2023/05/25321.7300.0021.3031122.66%
2023/05/24221.4500.0021.6521121.77%
2023/05/23421.0000.0020.8541113.60%
2023/05/19420.1000.0020.1041093.66%
2023/05/18220.1000.0020.3021091.83%
2023/05/09520.9200.0021.5551054.74%
2023/03/1400.004220.0220.10-4240-104.26%
2022/08/1800.00111.2011.20-1111-0.89%
2022/05/12314.2500.0013.7031492.01%
2022/05/1100.000.114.2014.25-0.1145-0.10%
2022/02/2100.00115.4015.50-199-1.00%
2021/11/1200.00115.7515.45-182-1.22%
2021/11/11115.9500.0016.001821.22%
2021/11/10116.5000.0016.501751.33%
2021/08/0400.00115.9016.00-1369-0.27%
2021/06/10116.5500.0016.7014770.21%
2020/12/2800.00117.4517.20-1353-0.28%
2020/10/2300.002019.2419.70-20548-3.64%
2020/10/222022.4400.0021.20205613.56%
2020/08/0600.000.124.5024.30-0.12,3020.00%
2020/07/300.125.1000.0025.250.12,2720.00%
2020/07/2200.00127.4530.00-12,204-0.05%
2020/07/21125.800.127.4527.450.92,1490.04%
2020/07/200.125.00124.9025.00-0.92,109-0.04%
2020/07/1700.000.126.1526.15-0.12,0680.00%
2020/07/16130.00129.1529.0502,0180.00%
2020/07/151.130.5100.0030.801.11,9830.05%
2020/07/1400.00330.2029.60-31,907-0.16%
2020/07/13330.00231.3031.5511,7930.06%
2020/07/10428.7000.0028.7041,6660.24%
2020/07/0900.00426.1026.10-41,530-0.26%
2020/07/07122.00121.1521.6001,5050.00%
2020/07/06223.5500.0023.1521,4760.14%
2020/07/0100.003024.0024.00-301,420-2.11%
2020/06/1700.002826.1125.35-281,350-2.07%
2020/06/16224.10325.5025.90-11,294-0.08%
2020/06/1200.00421.4022.00-41,124-0.36%
2020/06/11120.4000.0021.0011,0770.09%
2020/05/2700.00419.4519.45-4947-0.42%
2020/05/25119.60518.5519.65-4935-0.43%
2020/05/22817.68117.0017.9079300.75%
2020/05/20114.8500.0014.8518270.12%
2020/03/3000.00558.598.57-55678-8.11%
2020/03/2700.0028.838.80-2675-0.30%
2020/03/2500.00188.278.08-18663-2.71%
2020/03/043615.0200.0014.95364597.84%
2020/03/034214.1700.0015.45424349.66%
2020/02/25111.9000.0012.8012640.38%
2020/01/1400.002910.3010.40-29105-27.44%
2020/01/072910.2000.0010.452910128.51%
2019/12/2500.00510.1010.00-570-7.13%
2019/04/0900.00312.5012.40-3153-1.95%
2019/04/0100.00312.4512.50-3152-1.97%
2019/03/1500.00113.1512.90-1145-0.69%
2019/01/24113.2000.0013.3011100.90%
2019/01/17113.5500.0013.5011070.93%
2019/01/1500.000.213.4013.40-0.2101-0.23%
2019/01/0800.00612.1512.20-661-9.71%
2019/01/0700.00111.2511.10-154-1.83%
2018/12/1100.00311.1711.20-360-4.94%
2018/11/0500.00211.6511.70-290-2.21%
2018/09/1700.00116.9016.85-1120-0.83%
2018/05/3000.001018.2018.20-10392-2.55%
2018/04/1900.001020.0320.90-10358-2.79%
2018/04/1700.00120.5520.55-1342-0.29%
2018/04/16521.3500.0021.3553291.52%
2018/04/1300.0028.324.0523.70-28.3302-9.35%
2018/04/11523.45422.5422.9012320.43%
2018/04/10222.851022.8522.85-8189-4.21%
2018/03/1600.001019.5519.55-10186-5.35%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音